Can a Dominant Health Insurer’s Refusal to Negotiate in Good Faith Be Actionable under the Antitrust Laws? Yes, Says a Federal Court in Rhode Island

Click here to read the full article online

Our article highlights new antitrust risks for market participants in the largest sector of the U.S. economy: healthcare. We write about an important expansion of “refusal to deal” liability under Section 1 of the Sherman Act.